Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


Ginkgo Bioworks Holdings, Inc. (DNA) reported on Monday that third-quarter net loss attributable to the company sharply widened to $101.88 million or $0.08 per share from $26.06 million or $0.02 per share in the prior-year quarter.


RTTNews | Nov 15, 2021 07:58AM EST

07:58 Monday, November 15, 2021 (RTTNews.com) - Ginkgo Bioworks Holdings, Inc. (DNA) reported on Monday that third-quarter net loss attributable to the company sharply widened to $101.88 million or $0.08 per share from $26.06 million or $0.02 per share in the prior-year quarter.

Total revenue for the quarter soared to $77.61 million from $13.30 million in the same quarter last year.

On average, analysts polled by Thomson Reuters expected the company to report a loss of $0.03 per share on revenues of $45.75 million for the quarter. Analysts' estimates typically exclude special items.

Looking ahead to fiscal 2021, Ginkgo expects total Foundry revenue of at least $100 million, inclusive of both downstream value share and services revenue. It also now expects Biosecurity revenue to be at least $110 million.

Read the original article on RTTNews ( https://www.rttnews.com/3242359/ginkgo-bioworks-q3-loss-sharply-widens-quick-facts.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC